Year |
Citation |
Score |
2013 |
Henry KE, Balasingham RG, Vortherms AR, Platts JA, Valliant JF, Coogan MP, Zubieta J, Doyle RP. Emission wavelength variation with changes in excitation in a Re(i)-bisthiazole ligand complex that breaks the Kasha-Vavilov rule Chemical Science. 4: 2490-2495. DOI: 10.1039/C3Sc22070B |
0.677 |
|
2011 |
Vortherms AR, Kahkoska AR, Rabideau AE, Zubieta J, Andersen LL, Madsen M, Doyle RP. A water soluble vitamin B 12-Re(I) fluorescent conjugate for cell uptake screens: Use in the confirmation of cubilin in the lung cancer line A549 Chemical Communications. 47: 9792-9794. PMID 21818500 DOI: 10.1039/C1Cc13615A |
0.571 |
|
2011 |
Bartholomä MD, Vortherms AR, Hillier S, Joyal J, Babich J, Doyle RP, Zubieta J. Synthesis, cytotoxicity and cellular uptake studies of N3 functionalized Re(CO)3 thymidine complexes Dalton Transactions. 40: 6216-6225. PMID 21369609 DOI: 10.1039/C0Dt01452D |
0.602 |
|
2010 |
Bartholomä MD, Vortherms AR, Hillier S, Ploier B, Joyal J, Babich J, Doyle RP, Zubieta J. Synthesis, cytotoxicity, and insight into the mode of action of Re(CO) 3 thymidine complexes Chemmedchem. 5: 1513-1529. PMID 20652929 DOI: 10.1002/Cmdc.201000196 |
0.578 |
|
2010 |
Marino N, Vortherms AR, Hoffman AE, Doyle RP. Expanding monomeric pyrophosphate complexes beyond platinum Inorganic Chemistry. 49: 6790-6792. PMID 20429603 DOI: 10.1021/Ic1006007 |
0.651 |
|
2009 |
Vortherms AR, Dang HN, Doyle RP. Anticancer conjugates and cocktails based on methotrexate and nucleoside synergism. Clinical Medicine. Oncology. 3: 19-26. PMID 20689607 DOI: 10.4137/Cmo.S2113 |
0.577 |
|
2008 |
Vortherms AR, Doyle RP, Gao D, Debrah O, Sinko PJ. Synthesis, characterization, and in vitro assay of folic acid conjugates of 3'-azido-3'-deoxythymidine (AZT): toward targeted AZT based anticancer therapeutics. Nucleosides, Nucleotides & Nucleic Acids. 27: 173-85. PMID 18205071 DOI: 10.1080/15257770701795946 |
0.579 |
|
2008 |
Viola-Villegas N, Vortherms A, Doyle RP. Targeting Gallium to Cancer Cells through the Folate Receptor Drug Target Insights. 3: DTI.S651. DOI: 10.4137/Dti.S651 |
0.689 |
|
2007 |
Petrus AK, Vortherms AR, Fairchild TJ, Doyle RP. Vitamin B12 as a carrier for the oral delivery of insulin Chemmedchem. 2: 1717-1721. PMID 17896339 DOI: 10.1002/Cmdc.200700239 |
0.661 |
|
2007 |
Petrus A, Vortherms A, Fairchild T, Doyle R. Cover Picture: Vitamin B12 as a Carrier for the Oral Delivery of Insulin (ChemMedChem 12/2007) Chemmedchem. 2: 1661-1661. DOI: 10.1002/Cmdc.200790041 |
0.66 |
|
Low-probability matches (unlikely to be authored by this person) |
2023 |
Kelly M, Mandlik A, Charles RC, Verma S, Calderwood SB, Leung DT, Biswas R, Islam K, Kamruzzaman M, Chowdhury F, Khanam F, Vann WF, Khan AI, Bhuiyan TR, Qadri F, ... Vortherms AR, et al. Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry. Vaccine. PMID 37400283 DOI: 10.1016/j.vaccine.2023.06.052 |
0.102 |
|
2018 |
Turbyfill KR, Clarkson KA, Vortherms AR, Oaks EV, Kaminski RW. Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy ofArtificial Invaplex. Msphere. 3. PMID 29600284 DOI: 10.1128/mSphere.00583-17 |
0.064 |
|
2023 |
Turbyfill KR, Clarkson KA, Oaks EV, Zurawski DV, Vortherms AR, Kaminski RW. Development of the 2a, 3a, 6, and artificial Invaplex (Invaplex) vaccines. Msphere. e0007323. PMID 37389412 DOI: 10.1128/msphere.00073-23 |
0.054 |
|
Hide low-probability matches. |